RxDoctor Payments DataLook up a doctor →

Rachael Daley

Adult Health · Avondale, AZNPI 1558577320

Payments from drug & device makers

$8,994in general payments, 2019–2025

Across 616 payments — averaging $14.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • UCB, Inc.$1K
  • Teva Pharmaceuticals USA, Inc.$876
  • Novartis$604
  • Lilly USA, LLC$399
  • EMD Serono, Inc.$392
  • plus $4K from 41 others

What the payments were for

  • Food & beverage$8,958100%
  • Education$360%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,994 in reported general payments places this provider in the 95th percentile of 314 adult health providers in Arizona.

See all adult health providers in Arizona

Medicare billing

Part B allowed, 2024
$13,507
Medicare patients
113
Services billed
128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OctagamImmun Globg(Igg)/Malt/Iga Ov5013$105,740
Emgality PenGalcanezumab-Gnlm81$68,215
Aimovig AutoinjectorErenumab-Aooe74$61,197
Nurtec OdtRimegepant Sulfate37$57,679
QuliptaAtogepant36$39,242
UbrelvyUbrogepant27$38,968
Ajovy AutoinjectorFremanezumab-Vfrm40$38,244
NuedextaDextromethorphan Hbr/Quinidine18$28,000
BriviactBrivaracetam19$21,831
AptiomEslicarbazepine Acetate13$18,723
Memantine Hcl484$14,142
Gabapentin637$12,288
NeuproRotigotine11$10,294
Topiramate ErTopiramate11$10,231
Duloxetine Hcl252$9,239

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerOctagam, Nurtec Odt$251$163,42050 claims
AbbVieQulipta, Ubrelvy, Namzaric$1,964$86,24474 claims
UCB, Inc.Briviact, Neupro$1,039$32,12630 claims
Avanir Pharmaceuticals, Inc.Nuedexta$83$28,00018 claims
Upsher-smith Laboratories LLCTopiramate$20$4,890458 claims
Amneal Pharmaceuticals LLCMycophenolate Mofetil$180$1,16014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 314 adult health providers in Arizona.

Other adult health in Avondale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →